United States · FDA National Drug Code directory

Syprine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0187-2120_38dd4547-62ef-4e2f-afc2-bfe43eb86b8d
Product NDC
0187-2120
Form
CAPSULE
Composition / generic term
trientine hydrochloride
Labeler
Bausch Health US LLC
Marketing category
NDA
Marketing start / end (source format)
19851108
Source listing expiry
20261231

Source-listed ingredients

  • TRIENTINE HYDROCHLORIDE — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (0187-2120-10) / 100 CAPSULE in 1 BOTTLE · 0187-2120-10

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →